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ABSTRACT
Introduction. To evaluate the safety of needle electromy-
ography (EMG) in critically ill intensive care unit (ICU) 
patients who are on anticoagulants and have comorbidities 
that increase the risk of bleeding and infections.
Methods. We conducted a retrospective chart review of 
critically ill patients who underwent needle EMG studies. 
The most common complications following needle EMG 
were reviewed and classified based upon common terminol-
ogy criteria for adverse events (CTAC) criteria. Descriptive 
statistics were reported using the frequencies and percent-
ages for categorical variables. Mean and interquartile range 
is used for continuous variables. All analyses were con-
ducted using the Statistical Package for the Social Sciences 
(IBM SPSS Statistic Version 21, IMB Inc., Chicago, IL.
Results. Twenty-nine patients were included. 17 (58.6%) 
were males with a mean age of 60.8 +/- 16.7 years.  The 
mean PT, PTT, and INR were 15.2 sec, 36.5 seconds, and 
1.13, respectively. Fourteen (48.2%) patients in this cohort 
were treated with low molecular weight heparin (LMWH), 
and an additional 8 (27.5%) patients were administered 
subcutaneous (SC) heparin for deep vein thrombosis pro-
phylaxis. Therapeutic heparin was being used in 3 (10.3%) 
patients and sequential compression devices (SCDs) in 4 
(13.7%) patients. A total of 228 muscles were tested. Among 
them, 38 (16.6%) were deep muscles. There were no major 
bleeding complications at the time of the procedure and for 
the next seven days in any of the patients, including those 
with multiple medical comorbidities. All our patients met 
the grade 1 scale in the severity of adverse events criteria 
proposed by CTCAE.
Conclusion. Needle EMG is safe in critically ill ICU pa-
tients on anticoagulants and multiple comorbidities includ-
ing those that increase the risk of bleeding and infection.
Keywords: Needle EMG, ICU patients, Electro-Diagnostic 
Study, Safety of EMG, EMG in Critically Ill. 
Introduction
Needle electromyography (EMG) is routinely per-
formed in patients with suspected myopathy and peripheral 
nervous system disorders. The needle EMG portion of the 
electro diagnostic testing can be a painful and uncomfort-
able procedure but is generally well tolerated and poses very 
little risk to patients (1). The rare complications associated 
with the needle EMG include local bleeding, hematoma, in-
fection, pneumothorax, and nerve injury (2). There are no 
absolute contraindications to the needle EMG procedure 
according to the guidelines proposed by the American As-
sociation of neuromuscular and electro diagnostic medicine 
(AANEM). The diagnostic yield of these studies, in many 
cases, outweighs the risks associated with the procedure in 
making a definite diagnosis (3). The safety of needle EMG 
has been studied extensively in a healthy population, pa-
tients on antiplatelet medications, and anticoagulant medi-
cations such as warfarin and non-vitamin K oral anticoagu-
lants (4). Performing a detailed neurological examination in 
critically ill patients can be difficult, and electro diagnostic 
studies provide valuable information in these patients. Pa-
tients who are critically ill and in the intensive care unit 
(ICU) have multiple comorbidities and are sometimes ad-
mitted in the ICU for an underlying neuromuscular disor-
der.
However, the safety of needle EMG in critically ill ICU 
patients remains unknown. The objective of our study is to 
determine the safety of needle EMG procedures in critically 
ill ICU patients.
Methods  
Basic demographic and the coexisting ICU comorbid 
conditions, coagulation studies such as prothrombin time 
(PT), partial thromboplastin time (PTT), international 
normalized ratio (INR) within 24 hours before the needle 
EMG procedure were reviewed.  Thrombocytopenia de-
fined as a platelet count of less than 150,000 (5). Detailed 
histories, along with the indications for the usage, type of 
anticoagulation, and the concurrent usage of antiplatelet, 
were reviewed.
Needle EMG was performed as per the standard pro-
tocol and included both superficial and deep muscle groups 
(we classified muscles as deep if the muscle needed to be 
reached by traversing through another muscle or located 
next to a bony prominence) (6).
32
New Discoveries/New Stuff
All the patients in our study underwent nerve con-
duction studies which include the motor  (median, ulnar, 
tibial and fibular nerves), sensory nerve conduction studies 
(median, ulnar, superficial fibular and sural nerves), repeti-
tive nerve stimulus, phrenic nerve conduction studies, and 
needle electromyography as per the standard guidelines 
proposed by the American Association of neuromuscular & 
electro diagnostic Medicine (AANEM) (6).
A retrospective chart review of commonly reported 
complications such as infection, bleeding, pneumothorax, 
compartment syndrome, and necrotizing fasciitis reviewed 
for seven days following the procedure. The infections dur-
ing and after the needle EMG in critically ill patients were 
classified based on the definition of infection in patients 
with sepsis proposed by the international sepsis forum 
consensus conference (7). The hemorrhagic complications 
were classified based on the bleeding academic research 
consortium definition for bleeding (8). All our patients had 
a chest x-ray on the following day, the results were reviewed 
for pneumothorax, and electronic medical records (EMR) 
were reviewed for the occurrence of compartment syn-
drome. Finally, the severity of the adverse events was classi-
fied based on the common terminology criteria for adverse 
events (CTCAE) (9).
Descriptive statistics were reported using the frequen-
cies and percentages for categorical variables. The mean 
and interquartile range is used for continuous variables. All 
analyses were conducted using the Statistical Package for 
the Social Sciences (IBM SPSS Statistic Version 21, IMB 
Inc., Chicago, IL.
Results
Twenty-nine patients were included in this study.  Reason 
for the exclusion of other patients is described in the figure 1.
Among them, 17 (58.6%) were males, and 12(41.4%) 
were females with a mean age of 60.8 +/- 16.7 years (mean 
+/- SD). The mean prothrombin time (PT) and partial 
thromboplastin time (PTT) were 15.2 (normal 13.8- 15.8 
seconds) and 36.5 seconds (normal 27-37seconds), respec-
tively. The mean International Normalized Ratio (INR) 
was 1.13 (normal INR- 0.9-1.1) of 23 patients who were on 
anti-coagulation, excluding the four patients with subcuta-
neous compression devices. Thrombocytopenia was seen in 
7 (23%) patients. Fourteen (48.2%) patients in this cohort 
were treated with low molecular weight heparin (LMWH), 
and an additional 8(7.5%) patients were administered sub-
cutaneous (SC) heparin for deep vein thrombosis prophy-
laxis. Therapeutic Intravenous (IV) heparin was being used 
in 3 (10.3%) patients and sequential compression devices 
(SCDs) used in 4 (13.7%) patients.  Five (17.2%) patients 
were on aspirin, and the rest of them were not on any an-
tiplatelet therapy. Twenty (69%) patients had at least one 
comorbid condition such as cardiovascular disease, malig-
nancy, renal failure, or diabetes mellitus. The most common 
indication for needle EMG study was a generalized weak-
ness in 21 (72.4%), difficulty to wean off the ventilator in 
4 (13.7%), bilateral lower extremity weakness in 2 (6.8%), 
hemi-facial weakness in 1(3.4%), and neck weakness in 1 
(3.4%) patient. Out of 29 patients, 26 underwent upper 
and lower extremity nerve conduction studies, and three 
patients exclusively underwent repetitive nerve stimulus 
along with needle EMG. Among 26 patients, four of them 
who had difficulty in weaning from the ventilator underwent 
phrenic nerve conduction studies, MRI of the C-spine, and 
ultrasound of the diaphragm. At the time of needle EMG 
study, 8 (33.3%) patients met the definition for the infection 
proposed by the international sepsis forum consensus con-
ference. A total of 228 muscles were tested. Among them, 
38 (16.6%) were deep muscle groups. The muscle groups 
are summarized in table 1.  
None of the patients required any immediate interven-
tion to prevent bleeding, and none had visible clinical hema-
toma following the procedure, including those patients who 
had thrombocytopenia. Also, none of the patients required a 
radiological evaluation for hematoma during the next seven 
days of chart review. Twenty-one (72.5%) patients had no 
signs of infection, including superficial and deep tissue in-
fections, and this remained unchanged at seven-day follow-
up. None of the patients had a pneumothorax (on follow 
up imaging: chest x-ray) or compartment syndrome. All 
our patients met the grade 1 scale in the severity of adverse 
events criteria proposed by CTCAE. Diagnosis of the un-Figure 1: Reason for exclusion 
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derlying neuromuscular condition was made in 93% of the 
patients that underwent needle EMG study, and the details 
summarized in table 2.  
Discussion
In this study, we assessed the safety of needle EMG 
in patients who are critically ill and found the procedure 
to be relatively safe with only mild complications based on 
CTCAE criteria. No patients had secondary complications 
such as infection, hematoma, pneumothorax, compartment 
syndrome for seven days following the electro diagnostic 
studies. 
Superficial and deep tissue infections are rarely report-
ed in patients who underwent EMG studies, and the risk is 
estimated to be less than 1/10,000 (2). Burris et al. reported 
the first case of cellulitis after the needle EMG, and another 
case series described six patients who had skin and soft tis-
sue infection (10, 11).  In both studies, EMG was done using 
a reusable needle. We believe the reported cases of infec-
tion may have been due to improper sterilization techniques 
rather than the standard electro diagnostic procedure itself. 
The previous practice of performing needle EMG by using 
a reusable needle has been replaced by using disposable fine 
concentric needle electrodes. We are unaware of superficial 
infection after the introduction of disposable needles in 
clinical practice. In our study, 21 out of 29 who are critically 
ill with multiple comorbidities underwent needle EMG, 
and none of them had superficial skin infections or usage of 
antibiotics on follow up. These findings suggest that needle 
EMG testing might be safe even in critically ill patients with 
multiple comorbidities. 8 of the 29 patients were taking an-
tibiotics during needle EMG studies and continued to be on 
them during follow up. Of the five patients in our study with 
lymphedema that underwent EMG procedure, none of the 
patients had an infection or required antibiotics on the fol-
low up.   
The AANEM recommends exercising caution while 
performing needle EMG in patients with platelets counts 
less than 50,000 IU, INR >1.5-2.0, or PT >1.5-2.0 seconds. 
(AAEM guidelines, 1999) (3). In our study, seven patients 
had thrombocytopenia, and their platelet counts ranged 
between 95,000-1, 40,000 number/ vol. Units, and none 
of them had immediate bleeding complications. Clinically 
significant bleeding complications are very rare following 
needle EMG procedure, and isolated case reports have been 
Table 1: Muscle groups tested in critically ill patients who 
underwent needle EMG. 
Muscles checked Frequency of muscles 
Deltoid 25
First Dorsal interossei 25
Biceps 22
Triceps 13
Iliopsoas 8
Trapezius 5
Cervical paraspinal 2
Thoracic paraspinal 2
Lumbar paraspinal 1
Vastus medialis 25
Mentalis 1
Tensor fascia lata 10
Frontalis 1
Orbicularis oculi 1
Gastrocnemius 24
Pronator teres 17
Tibialis posterior 1
Extensor digitorum communis 9
Tibialis anterior 27
Rectus femoris 1
Extensor indicis pollicis 3
Abductor pollicis brevis 5
Total 228
Table 2: Summary of diagnosis from electrodiagnostic study 
Diagnosis No. of patient
Critical illness neuropathy/
Myopathy 
7(24.1%) 
Guillain-Barré Syndrome and its 
variants 
 7(24.1%)
Generalized Sensory motor 
Polyneuropathy
4(13.7%)
Motor Neuron disease 4(13.7%)
Myasthenia gravis 2 (6.9%)
Normal 1(3.4%)
Inflammatory Myopathy 1(3.4%)
Vasculitis Neuropathy 1(3.4%)
Inconclusive 2(6.9)
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reported in patients on therapeutic anticoagulation (12, 13, 
14). The overall incidence of subclinical hematoma identi-
fied by ultrasound and other studies involving both superfi-
cial and deep muscle groups after a needle EMG procedure 
ranges between 0.62 and 1.45% (4, 15). Both studies includ-
ed patients on therapeutic warfarin, antiplatelet agents, and 
healthy controls. In our study, three patients were on thera-
peutic anticoagulation at the time of the study. Very limited 
data is available on the safety of electro diagnostic studies 
in patients on prophylactic subcutaneous heparin or low 
molecular weight heparin.  Gertken et al. did a retrospec-
tive chart review of 370 patients who underwent electro 
diagnostic studies and magnetic resonance imaging (MRI) 
of the spine within one week following the procedure. Four 
of those patients were on prophylactic anticoagulation (2 
patients were on heparin while one patient each was on 
LMWH and dalteparin), and none had a symptomatic or 
asymptomatic hematoma on follow up imaging (16). In our 
study, 21 (72.5%) patients were on prophylactic anticoagu-
lation and did not require immediate intervention or evalu-
ation for hematoma following the procedure though, none 
of them had follow-up imaging for the assessment of hema-
toma.  We believe patients may or may not have had asymp-
tomatic bleeding following needle EMG, and it is consistent 
with the grade 1 scale in the severity of adverse events crite-
ria proposed by CTCAE. 
Compartment syndrome is a very rare complication 
after the standard needle EMG study. In our literature 
review, two isolated case reports with compartment syn-
drome following electro diagnostic studies were identified. 
In both cases, symptoms started immediately and slowly 
progressed in the next few hours before it became clinically 
evident. Accidental damage to the blood vessels might be 
the potential cause in these patients (17, 18). None of our 
patients had compartment syndrome even in the presence 
of multiple comorbidities and lymphedema. 
Pneumothorax is a rare and potentially lethal complica-
tion after the needle EMG procedure. The high-risk muscle 
groups include serratus anterior, supraspinatus, rhomboids, 
diaphragm, trapezius, and cervical paraspinal muscles. Kas-
sardjian et al. retrospectively reviewed 64,490 patients that 
were diagnosed with pneumothorax over 18 years. Among 
them, only seven patients had pneumothorax primarily due 
to electro diagnostic studies. In the same study, 22 patients 
also had a pneumothorax, which is temporally associated 
with EMG studies but was believed to be due to other causes 
such as lung biopsy or thoracoc   entesis.  In their series, the 
risk for the development of pneumothorax is higher in the 
serratus anterior (0.445%) and diaphragm (0.149%) fol-
lowed by trapezius (0.117%) with the lowest risk from cer-
vical (0.004%) and thoracic (0.003%) paraspinal muscles 
(19). All of the patients that had symptoms due to the pneu-
mothorax the diagnosis were confirmed within 24 hours 
following electro diagnostic study. In our study population, 
we sampled only the trapezius and paraspinal muscles, and 
none had symptomatic pneumothorax in the follow-up im-
aging using a chest x-ray.  
The following are the limitations of this study. The pro-
cedure technique varies between different electromyogra-
phers, making it difficult to generalize the conclusions from 
our findings. It is possible that the patients might have had 
asymptomatic bleeding secondary to needle EMG during 
follow-up.  Few patients were already on antibiotics for vari-
ous reasons before the needle EMG, it was difficult to assess 
for infection rate secondary to the procedure. Finally, it is 
noteworthy to mention that the authors were not blinded 
to the patient’s condition, i.e., the comorbid conditions and 
the anticoagulation status. Another limitation is that the 
diaphragm and serratus anterior was not examined in any 
patient in this series.  
Conclusion
Needle EMG of commonly tested superficial and deep 
muscles is safe in critically ill ICU patients who are on an-
ticoagulants and have multiple medical co-morbidities in-
cluding those that increase the risk of infection and bleeding.
Summary
Electro diagnostic studies like nerve conduction stud-
ies and needle EMG is gold-standard test in the evalua-
tion of peripheral nerve disorders. American Association 
of Neuromuscular and Electro diagnostic Medicine (AA-
NEM) recommends that there is no absolute contraindica-
tion to perform needle EMG. However, they recommend 
being cautious in patients on medically induced coagulopa-
thy and thrombocytopenia. Patients admitted to ICU have 
multiple comorbidities and prone to have complications 
from the medical procedures and diagnostic evaluations. 
However, the safety of the needle EMG in critically ill is un-
known. Our stud evaluated the safety of needle EMG in pa-
tients with multiple comorbidities and evaluated for various 
complications like bleeding, infection, pneumothorax, and 
compartment syndrome. No major complications are found 
based on our study. Also, all our patients met the grade 1 
scale in the severity of adverse events criteria proposed by 
CTCAE.
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